Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer.

Schmitz-Dräger BJ, Todenhöfer T, van Rhijn B, Pesch B, Hudson MA, Chandra A, Ingersoll MA, Kassouf W, Palou J, Taylor J, Vlahou A, Behrens T, Critelli R, Grossman HB, Sanchez-Carbayo M, Kamat A

Open source

DOI
10.1016/j.urolonc.2013.10.010
Published
2014 Oct
Container
Urologic oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.urolonc.2013.10.010,
  title = {Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer.},
  author = {Schmitz-Dräger BJ and Todenhöfer T and van Rhijn B and Pesch B and Hudson MA and Chandra A and Ingersoll MA and Kassouf W and Palou J and Taylor J and Vlahou A and Behrens T and Critelli R and Grossman HB and Sanchez-Carbayo M and Kamat A},
  year = {2014},
  journal = {Urologic oncology},
  doi = {10.1016/j.urolonc.2013.10.010},
  url = {https://doi.org/10.1016/j.urolonc.2013.10.010}
}

RIS

TY  - JOUR
TI  - Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer.
AU  - Schmitz-Dräger BJ
AU  - Todenhöfer T
AU  - van Rhijn B
AU  - Pesch B
AU  - Hudson MA
AU  - Chandra A
AU  - Ingersoll MA
AU  - Kassouf W
AU  - Palou J
AU  - Taylor J
AU  - Vlahou A
AU  - Behrens T
AU  - Critelli R
AU  - Grossman HB
AU  - Sanchez-Carbayo M
AU  - Kamat A
PY  - 2014
JO  - Urologic oncology
DO  - 10.1016/j.urolonc.2013.10.010
UR  - https://doi.org/10.1016/j.urolonc.2013.10.010
ER  - 

APA

BJ, S., T, T., B, V. R., B, P., MA, H., A, C., MA, I., W, K., J, P., J, T., A, V., T, B., R, C., HB, G., M, S., & A, K. (2014). Considerations on the use of urine markers in the management of patients with low-/intermediate-risk non-muscle invasive bladder cancer.. Urologic oncology. https://doi.org/10.1016/j.urolonc.2013.10.010

Source records